CiounMet G1

Glimepiride 1 & 2 mg with Metformin 500 mg (SR) Tablets

Effective in Diabetic Patients with Cardiac Complications

• Together achieves good glycemic control with better tolerability profile
• More effective than either drug alone for reducing glucose levels
• Exhibits weight neutralizing effects Safe for hypertensive & cardiac patients

CiounMet G2

Glimepiride 1 & 2 mg with Metformin 500 mg (SR) Tablets

Effective in Diabetic Patients with Cardiac Complications

• Together achieves good glycemic control with better tolerability profile
• More effective than either drug alone for reducing glucose levels
• Exhibits weight neutralizing effects Safe for hypertensive & cardiac patients

CiounMet G1/1000

Metformin 1000 mg (SR) & Glimepiride 1mg/2 mg Tablets

The Power of Two in One

• Low risk of mortality compared to other SU+Met. Combinations
• Negligible risk of hypoglycemia
• Better Survival rates

CiounMet G2/1000

Metformin 1000 mg (SR) & Glimepiride 1mg/2 mg Tablets

The Power of Two in One

• Low risk of mortality compared to other SU+Met. Combinations
• Negligible risk of hypoglycemia
• Better Survival rates

CiounMet-PG

Glimepiride 1 mg + Metformin 500 mg (SR) + Pioglitazone 15 mg Tablets

• Significant glycemic control in patients uncontrolled on dual therapy
• Increased Insulin sensitivity and B-cell function
• Delay in time to use exogenous insulin
• Low incidence of hypoglycemia
• Better Patient convenience

Cioun Met SG/500

Sitagliptin 50 mg + Metformin 500/1000 mg (SR) Tablets

Add Colors in Life...

• Sitagliptin is an oral, potent & selective dipeptidyl peptidase-4 enzyme (DPP-4) inhibitor
• Provides effective glucose lowering and well tolerated in patients with type 2 diabetes
• TECOS Trial- Confirms CV Safety Profile of Sitagliptin
• Reduces HbA1c, fasting & post prandial glucose concentration by glucose dependent stimulation of insulin secretion and inhibition of glucagon secretion
• Delays gastric emptying and reduce appetite Noval and affordable drug

Cioun Met SG/1000

Sitagliptin 50 mg + Metformin 500/1000 mg (SR) Tablets

Add Colors in Life...

• Sitagliptin is an oral, potent & selective dipeptidyl peptidase-4 enzyme (DPP-4) inhibitor
• Provides effective glucose lowering and well tolerated in patients with type 2 diabetes
• TECOS Trial- Confirms CV Safety Profile of Sitagliptin
• Reduces HbA1c, fasting & post prandial glucose concentration by glucose dependent stimulation of insulin secretion and inhibition of glucagon secretion
• Delays gastric emptying and reduce appetite Noval and affordable drug